GLP-1 is thought to mediate this through inhibiting Rho GTPase in the cyclic adenosine 3,5-monophosphate (cAMP)/protein kinase A (PKA) pathway [25]
The cleavage of GIP(1-30)NH 2 subsequently results in GIP(3-30)NH 2 , a fragment that binds to the human GIP receptor with high affinity but does not have any intrinsic activation of the human GIP receptor in physiological concentrations ( Figure 1 The human GIP receptor can be found in multiple organs and tissues, reflecting its various physiological functions ( Beyond the pancreatic islet cells, the GIP receptor is expressed within the vascular system, including the heart and various endothelial cells
Most users find that injection site reactions during dose escalation follow the same diminishing pattern they experienced during initial treatment, peaking during the first 1 to 2 injections at the new dose and resolving by the third or fourth injection at that level
doi: 10.1016/0165-0327(95)00026-J 443 MisiakBoniewskiIMarliczWFrydeckaDSzulcARudzkiLet al
These serious complications, while uncommon, highlight the importance of proper screening before treatment